quant Healthcare Fund - Growth Option - Direct Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 19.3881 ↓ -0.21%
[as on 13 November, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 40 SMA
  • 500 SMA

Returns

CAGR returns till date

CAGR returns of quant Healthcare Fund - Growth Option - Direct Plan and its peers as on 13 November, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
quant Healthcare Fund - Growth Option - Direct Plan 24.47% -0.21% 1.74% 4.72% 2.83% 20.61% 21.37%---
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -9.29% -0.27% 0.2% 3.18% -6.26% -10.5% 4.93% 8.92% 13.82% 14.25%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth 0.75% -0.5% 1.2% 9.63% 2.07% 1.58% 11.19% 7.88% 12.9% 12.67%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 29.68% -0.01% 3.26% 10.03% 4.42% 26.07% 25.42% 20.65% 26.17% 15.92%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 3.39% -0.04% 1.28% 6.76% -0.65% 3.49% 12.47% 14.96% 19.21% 15.81%
SBI COMMA Fund - DIRECT PLAN - Growth 4.37% -0.55% 0.42% 4.29% -2.46% 6.57% 14.27% 9.88% 18.09% 14.96%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 32.34% -4.87%

Discrete returns (monthly)

MonthJan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026Oct 2026
Returns -5.07% 2.58% -5.34% 6.23% 5.07% 6.57% 2.82% 5.93% -2.83% -0.6%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 5.83%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
70.33% 5.57% (Arbitrage: 0.00%) 0.00% 0.00% -4.55%

Equity

NameSymbol / ISINSectorWeight %Other links
Glaxosmithkline Pharmaceuticals LtdGLAXO (INE159A01016)Pharmaceuticals & Biotechnology10.58%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology9.30%
Pfizer LtdPFIZER (INE182A01018)Pharmaceuticals & Biotechnology8.83%
Alivus Life SciencesALIVUS (INE03Q201024)Pharmaceuticals & Biotechnology8.08%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology7.03%
SMS Pharmaceuticals LimitedSMSPHARMA (INE812G01025)Pharmaceuticals & Biotechnology6.71%
IPCA Laboratories LtdIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology6.22%
Zydus Wellness LtdZYDUSWELL (INE768C01028)Food Products5.64%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology5.18%
Strides Pharma Science LtdSTAR (INE939A01011)Pharmaceuticals & Biotechnology2.45%
Sumitomo Chemical India LimitedSUMICHEM (INE258G01013)Fertilizers & Agrochemicals0.31%

Debt

NameIsinRatingWeight %Yield
91 Days Treasury Bill 03-Sep-2026IN002026X099N.A.0.70%5.20%
91 Days Treasury Bill 10-Sep-2026IN002026X107N.A.0.70%5.18%
91 Days Treasury Bill 17-Sep-2026IN002026X115N.A.0.70%5.00%
91 Days Treasury Bill 15-Oct-2026IN002026X156N.A.0.70%5.11%
91 Days Treasury Bill 22-Oct-2026IN002026X164N.A.0.70%5.10%
91 Days Treasury Bill 05-Nov-2026IN002026X180N.A.0.69%5.25%
91 Days Treasury Bill 19-Nov-2026IN002026X206N.A.0.69%5.26%
91 Days Treasury Bill 27-Nov-2026IN002026X214N.A.0.69%5.27%
Portfolio data is as on date 31 August, 2026

NAV history

quant Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history

DateNAV% change
13 November, 202619.3881 -0.21%
12 November, 202619.4297 -0.38%
11 November, 202619.5043 -0.55%
9 November, 202619.6117 2.91%
6 November, 202619.0563 0.76%
5 November, 202618.912 0.76%
4 November, 202618.7695 0.06%
3 November, 202618.7591 0.97%
2 November, 202618.5794 0.44%
30 October, 202618.4988 0.12%
29 October, 202618.4762 0.81%
28 October, 202618.3274 0.55%
27 October, 202618.2279 2.24%
26 October, 202617.8294 1.83%
23 October, 202617.5096 -1.44%
22 October, 202617.7659 -0.25%
21 October, 202617.81 -0.72%
19 October, 202617.9383 -1.19%
16 October, 202618.1549 -0.64%
15 October, 202618.2715 -0.41%
14 October, 202618.3464 -0.91%
13 October, 202618.5141 0.37%
12 October, 202618.4455 0.35%
9 October, 202618.3807 0.91%
8 October, 202618.2141 -2.33%
7 October, 202618.6491 -0.82%
6 October, 202618.8031 1.11%
5 October, 202618.5959 -0.51%
1 October, 202618.6912 -0.9%
30 September, 202618.8601

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of quant Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of quant Healthcare Fund - Growth Option - Direct Plan is 19.3881 as on 13 November, 2026.
  • What are YTD (year to date) returns of quant Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of quant Healthcare Fund - Growth Option - Direct Plan are 24.47% as on 13 November, 2026.
  • What are 1 year returns of quant Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of quant Healthcare Fund - Growth Option - Direct Plan are 20.61% as on 13 November, 2026.
  • What are 3 year CAGR returns of quant Healthcare Fund - Growth Option - Direct Plan?
    The 3 year annualized returns (CAGR) of quant Healthcare Fund - Growth Option - Direct Plan are 21.37% as on 13 November, 2026.
  • What are top 10 holdings of quant Healthcare Fund - Growth Option - Direct Plan?
    Top 10 holdings of quant Healthcare Fund - Growth Option - Direct Plan are:
    • Glaxosmithkline Pharmaceuticals Ltd
    • Zydus Lifesciences Limited
    • Pfizer Ltd
    • Alivus Life Sciences
    • Concord Biotech Limited
    • SMS Pharmaceuticals Limited
    • IPCA Laboratories Ltd
    • Zydus Wellness Ltd
    • Aurobindo Pharma Limited
    • Strides Pharma Science Ltd
    • Sumitomo Chemical India Limited
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for quant Healthcare Fund - Growth Option - Direct Plan?
    quant Healthcare Fund - Growth Option - Direct Plan is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.